Skip to main content

HUPO, Amersham Road Show to Toot Proteomics

NEW YORK, June 3 - The Human Proteome Organization and Amersham Biosciences today kicked off a joint North American and European tour to discuss new research in proteomics and educate researchers about the recent advances and new technologies in the field.

 

The summer road show begins on today with researchers from Amersham and HUPO holding a seminar at Yale University.

 

Amersham Applications Manager Reiner Westermeier will discuss using mass spectrometry and 2D-gel electrophoresis in proteome analysis. HUPO representatives will also give updates on organization projects.

 

In the following ten days, researchers will visit universities and hotel conference centers in Piscataway, NJ; Quebec City; Montreal; Toronto; Ann Arbor, Mich., Minneapolis; Denver; Salt Lake City, and San Francisco.

 

HUPO presenters will include organization president Sam Hanash, University of Louisville's Peipei Ping, University of Texas Southwestern's Yingming Zhao, University of Michigan's David Beers, and the Van Andel Institute's Brian Haab.

 

The seminar is free. For further information, visit the Amersham website.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.